GOA Therapeutics files proposed $75 million Regulation A offering
AI Summary- GOA Therapeutics filed an SEC offering statement for a proposed Tier 2 Regulation A stock offering.
- The proposed offering covers 5 million shares at $15 each, totaling up to $75 million.
- GOA26 remains investigational, with human safety and efficacy not yet established.